8-PRENYLNARINGENIN INHIBITS BOTH P-GLYCOPROTEIN AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1

被引：0
|
作者：
Wesolowska, Olga [1 ]
Wisniewski, Jerzy [1 ]
Paprocka, Maria [2 ]
Dus, Danuta [2 ]
Michalak, Krystyna [1 ]
机构：
[1] Wroclaw Med Univ, Dept Biophys, PL-50368 Wroclaw, Poland
[2] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Med Immunol, Lab Cellular Interact, PL-53114 Wroclaw, Poland
来源：
ANTICANCER RESEARCH | 2008年 / 28卷 / 5C期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
725
引用
收藏
页码：3540 / 3541
页数：2
相关论文
共 50 条
  • [1] 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1
    Wesolowska, Olga
    Wisniewski, Jerzy
    Sroda, Kamila
    Krawczenko, Agnieszka
    Bielawska-Pohl, Aleksandra
    Paprocka, Maria
    Dus, Danuta
    Michalak, Krystyna
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2010, 644 (1-3) : 32 - 40
  • [2] Atazanavir inhibits P-glycoprotein and multidrug resistance-associated protein efflux activity
    Lucia, MB
    Golotta, C
    Rutella, S
    Rastrelli, E
    Savarino, A
    Cauda, R
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (05) : 635 - 637
  • [3] Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer
    Xu, H-W
    Xu, L.
    Hao, J-H
    Qin, C-Y
    Liu, H.
    [J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2010, 38 (01) : 34 - 42
  • [4] Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma
    Arts, HJG
    Katsaros, D
    de Vries, EGE
    Massobrio, M
    Genta, F
    Danese, S
    Arisio, R
    Scheper, RJ
    Kool, M
    Scheffer, GL
    Willemse, PHB
    van der Zee, AGJ
    Suurmeijer, AJH
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (10) : 2798 - 2805
  • [5] Schisandrin B: A dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1
    Sun, Meng
    Xu, Xiaoli
    Lu, Qinghua
    Pan, Qiangrong
    Hu, Xun
    [J]. CANCER LETTERS, 2007, 246 (1-2) : 300 - 307
  • [6] Decreased P-glycoprotein but unaltered multidrug resistance-associated protein in HIV patients
    Meaden, ER
    Brown, RA
    Hoggard, PG
    Maher, B
    Khoo, SH
    Back, DJ
    [J]. AIDS, 2000, 14 : S94 - S94
  • [7] Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison
    Seelig, A
    Blatter, XL
    Wohnsland, F
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2000, 38 (03) : 111 - 121
  • [8] Expression of Multidrug Resistance-Associated P-Glycoprotein in Feline Tumours
    Van der Heyden, S.
    Chiers, K.
    Vercauteren, G.
    Daminet, S.
    Wegge, B.
    Paepe, D.
    Ducatelle, R.
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2011, 144 (2-3) : 164 - 169
  • [9] EXPRESSION OF MULTIDRUG RESISTANCE-ASSOCIATED P-GLYCOPROTEIN IN FELINE TUMOURS
    Van der Heyden, S.
    Koen, C.
    Ducatelle, R.
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2009, 141 (04) : 311 - 311
  • [10] The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer
    Wen-Qing Hu
    Chun-Wei Peng
    Yan Li
    [J]. Journal of Experimental & Clinical Cancer Research, 28
12345